Cortisone reductase deficiency: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Cortisone Reductase Deficiency''' is a rare genetic condition that affects the metabolism of certain hormones. It is characterized by a reduced ability to convert the hormone cortisone to cortisol. This condition is caused by mutations in the genes encoding the enzymes 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and hexose-6-phosphate dehydrogenase (H6PD).
{{SI}}
{{Infobox medical condition
| name            = Cortisone reductase deficiency
| image          = [[File:PDB_1xu7_EBI.jpg|250px]]
| caption        = Structure of cortisone reductase
| field          = [[Endocrinology]]
| symptoms        = [[Hirsutism]], [[irregular menstruation]], [[infertility]], [[obesity]], [[hypertension]]
| complications  = [[Metabolic syndrome]], [[polycystic ovary syndrome]]
| onset          = Typically in [[adolescence]] or [[early adulthood]]
| duration        = [[Chronic (medicine)|Chronic]]
| causes          = Genetic mutation in the [[HSD11B1]] gene
| risks          = Family history of the condition
| diagnosis      = [[Blood test]], [[urine test]], [[genetic testing]]
| differential    = [[Cushing's syndrome]], [[polycystic ovary syndrome]], [[congenital adrenal hyperplasia]]
| treatment      = [[Lifestyle modification]], [[medication]]
| medication      = [[Metformin]], [[spironolactone]]
| prognosis      = Variable, depending on management
| frequency      = Rare
}}
[[File:Cortisone_Reductase_Deficiency_effects_on_HPA_and_body.png|Cortisone Reductase Deficiency effects on HPA and body|thumb|left]]
[[File:Cortisone_Reductase_Deficiency_effects_on_HPA_and_body_in_presence_of_deficient_H6PD.png|Cortisone Reductase Deficiency effects on HPA and body in presence of deficient H6PD|thumb|left]]


'''Cortisone Reductase Deficiency''' is a rare genetic condition that affects the metabolism of certain hormones. It is characterized by a reduced ability to convert the hormone cortisone to cortisol. This condition is caused by mutations in the genes encoding the enzymes 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and hexose-6-phosphate dehydrogenase (H6PD).
==Symptoms==
==Symptoms==
The symptoms of Cortisone Reductase Deficiency can vary widely, but often include [[hirsutism]], [[acne]], [[menstrual irregularities]], and [[obesity]]. Some individuals may also experience [[hypertension]], [[insulin resistance]], and [[glucose intolerance]].
The symptoms of Cortisone Reductase Deficiency can vary widely, but often include [[hirsutism]], [[acne]], [[menstrual irregularities]], and [[obesity]]. Some individuals may also experience [[hypertension]], [[insulin resistance]], and [[glucose intolerance]].
==Causes==
==Causes==
Cortisone Reductase Deficiency is caused by mutations in the [[HSD11B1]] and [[H6PD]] genes. These genes encode the enzymes 11β-HSD1 and H6PD, respectively, which are involved in the conversion of cortisone to cortisol.
Cortisone Reductase Deficiency is caused by mutations in the [[HSD11B1]] and [[H6PD]] genes. These genes encode the enzymes 11β-HSD1 and H6PD, respectively, which are involved in the conversion of cortisone to cortisol.
 
==Diagnosis==
==Diagnosis==
Diagnosis of Cortisone Reductase Deficiency is typically made through a combination of clinical examination, laboratory testing, and genetic testing. The diagnosis is confirmed by finding elevated levels of cortisone and reduced levels of cortisol in the urine, and by identifying mutations in the HSD11B1 and H6PD genes.
Diagnosis of Cortisone Reductase Deficiency is typically made through a combination of clinical examination, laboratory testing, and genetic testing. The diagnosis is confirmed by finding elevated levels of cortisone and reduced levels of cortisol in the urine, and by identifying mutations in the HSD11B1 and H6PD genes.
==Treatment==
==Treatment==
Treatment for Cortisone Reductase Deficiency is aimed at managing the symptoms and may include hormone replacement therapy, lifestyle modifications, and medications to control hypertension and insulin resistance.
Treatment for Cortisone Reductase Deficiency is aimed at managing the symptoms and may include hormone replacement therapy, lifestyle modifications, and medications to control hypertension and insulin resistance.
==See Also==
==See Also==
* [[Hormone]]
* [[Hormone]]
Line 19: Line 36:
* [[HSD11B1]]
* [[HSD11B1]]
* [[H6PD]]
* [[H6PD]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
[[Category:Endocrine disorders]]
[[Category:Endocrine disorders]]
[[Category:Rare diseases]]
[[Category:Rare diseases]]
{{stub}}
{{stub}}
<gallery>
File:PDB_1xu7_EBI.jpg|Cortisone Reductase Deficiency
File:Cortisone_Reductase_Deficiency_effects_on_HPA_and_body.png|Cortisone Reductase Deficiency effects on HPA and body
File:Cortisone_Reductase_Deficiency_effects_on_HPA_and_body_in_presence_of_deficient_H6PD.png|Cortisone Reductase Deficiency effects on HPA and body in presence of deficient H6PD
</gallery>

Latest revision as of 13:39, 5 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Cortisone reductase deficiency
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Hirsutism, irregular menstruation, infertility, obesity, hypertension
Complications Metabolic syndrome, polycystic ovary syndrome
Onset Typically in adolescence or early adulthood
Duration Chronic
Types N/A
Causes Genetic mutation in the HSD11B1 gene
Risks Family history of the condition
Diagnosis Blood test, urine test, genetic testing
Differential diagnosis Cushing's syndrome, polycystic ovary syndrome, congenital adrenal hyperplasia
Prevention N/A
Treatment Lifestyle modification, medication
Medication Metformin, spironolactone
Prognosis Variable, depending on management
Frequency Rare
Deaths N/A


Cortisone Reductase Deficiency effects on HPA and body
Cortisone Reductase Deficiency effects on HPA and body in presence of deficient H6PD

Cortisone Reductase Deficiency is a rare genetic condition that affects the metabolism of certain hormones. It is characterized by a reduced ability to convert the hormone cortisone to cortisol. This condition is caused by mutations in the genes encoding the enzymes 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and hexose-6-phosphate dehydrogenase (H6PD).

Symptoms[edit]

The symptoms of Cortisone Reductase Deficiency can vary widely, but often include hirsutism, acne, menstrual irregularities, and obesity. Some individuals may also experience hypertension, insulin resistance, and glucose intolerance.

Causes[edit]

Cortisone Reductase Deficiency is caused by mutations in the HSD11B1 and H6PD genes. These genes encode the enzymes 11β-HSD1 and H6PD, respectively, which are involved in the conversion of cortisone to cortisol.

Diagnosis[edit]

Diagnosis of Cortisone Reductase Deficiency is typically made through a combination of clinical examination, laboratory testing, and genetic testing. The diagnosis is confirmed by finding elevated levels of cortisone and reduced levels of cortisol in the urine, and by identifying mutations in the HSD11B1 and H6PD genes.

Treatment[edit]

Treatment for Cortisone Reductase Deficiency is aimed at managing the symptoms and may include hormone replacement therapy, lifestyle modifications, and medications to control hypertension and insulin resistance.

See Also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia